About ISAR Bioscience
ISAR Bioscience is a company based in Planegg (Germany) founded in 2018. The company has 19 employees. ISAR Bioscience offers products and services including Genome Editing and Human iPS Cells. ISAR Bioscience operates in a competitive market with competitors including Senti Biosciences, Avidity Biosciences, Poseida Therapeutics, Univercells and Sutro Biopharma, among others.
- Headquarter Planegg, Germany
- Employees 19
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website isarbioscience.de/en
- Social LinkedIn
- Legal Name Isar Bioscience Gmbh
- Latest Funding Round$1.01M (USD), Grant
Nov 2023
- Investors
- Employee Count19
Products & Services of ISAR Bioscience
ISAR Bioscience offers a comprehensive portfolio of products and services, including Genome Editing and Human iPS Cells.
Offers genome editing for research and therapy development
Provides induced pluripotent stem cells for disease therapies
Funding Insights of ISAR Bioscience
- Total Rounds 1
- Last Round Grant — $1.01M
- First Round $1.01M
(Nov 2023)
- Investors Count 1
All 1 funding rounds of ISAR Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2023 | $1.01M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in ISAR Bioscience
ISAR Bioscience has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for ISAR Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ISAR Bioscience
2 dated milestones of ISAR Bioscience across 5 years, from founding to its latest funding, stage changes and deals.
- Founded ISAR Bioscience is founded.
- Funding First funding round of $1.0M.
Competitors of ISAR Bioscience
ISAR Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Avidity Biosciences, Poseida Therapeutics, Univercells and Sutro Biopharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sentibio.com | 2016 | San Francisco, United States | $158M | – | Cell-based therapies for cancer treatment are developed. | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. |
Detailed competitors of ISAR Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ISAR Bioscience
The website of ISAR Bioscience (isarbioscience.de) receives about 2.7K visits a month.
- Monthly visits2.7K
▲ 23.5% vs previous month
Websites whose visitors overlap most with ISAR Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| metabion.com | 100% | – | #3,974,909 | View details | |
| amsilk.com | 99% | 2.6K | #6,008,623 | View details | |
| viramed.de | 98% | – | – | View details | |
amicusrx.de | amicusrx.de | 98% | – | #10,724,948 | – |
ibbnetzwerk-gmbh.com | ibbnetzwerk-gmbh.com | 95% | – | #10,824,615 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 18 similar websites and full traffic analytics for ISAR Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Isar Bioscience
Complete news archive for ISAR Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to ISAR Bioscience
10 companies that operate in the same segment as ISAR Bioscience (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ISAR Bioscience
ISAR Bioscience was founded in 2018 and raised its 1st funding round 5 years after it was founded.
ISAR Bioscience is headquartered in Planegg, Germany. It is registered at Planegg, Bavaria, Germany.
ISAR Bioscience has 19 employees.
ISAR Bioscience was founded in 2018 in Planegg, Germany, within the biotechnology sector focused on regenerative medicine. Induced pluripotent stem cell and genome engineering technologies are utilized by the company to develop therapeutic solutions. Operations include collaborations with ldc and Assay.Works to support discovery technologies and advance regenerative applications in healthcare.
ISAR Bioscience's top competitors include Sutro Biopharma, Avidity Biosciences and Senti Biosciences.
ISAR Bioscience offers Genome Editing and Human iPS Cells.
ISAR Bioscience has 1 investor. Key investors include European Union.
ISAR Bioscience operates through Isar Bioscience Gmbh.